Development and Testing of a Scale to Measure Symptom Distress Among Women Living With HIV/AIDS

2.50
Hdl Handle:
http://hdl.handle.net/10755/151668
Type:
Presentation
Title:
Development and Testing of a Scale to Measure Symptom Distress Among Women Living With HIV/AIDS
Abstract:
Development and Testing of a Scale to Measure Symptom Distress Among Women Living With HIV/AIDS
Conference Sponsor:Sigma Theta Tau International
Conference Year:2004
Conference Date:July 22-24, 2004
Author:Lindberg, Claire E., PhD, RN
P.I. Institution Name:The College of New Jersey
Title:Associate Professor
Co-Authors:Kathleen Casey, MD; Susan Bataille, RN
Objective: Development and testing of an instrument to measure physical symptoms in women with HIV/AIDS. Design: Methodological: Scale development and psychometric testing of the HIV Symptom Scale for Females (HIVSX-FEM). Population, Sample: Population/Dates: Adult women with HIVAIDS. 1999-2003. Two community-residing groups of seropositive women from a state with a high HIV/AIDS rates participated: 8 women in focus groups and 123 women completed questionnaires. The mean age of the participants was 41 (range 24-66). Sixty percent were black, 27% were white and 7% were Latina. Variables: Symptom distress: Measured using the HIVSX-FEM, a 28-item self-report scale. Health-related quality of life: Measured using the Medical Outcomes Scale–HIV (MOS-HIV). HIV-related mental distress: Measured with the HIV Impact Scale for Women (HIVIS-W). HIV status measured with standard disease indicators. Methods: HIVSX-FEM items were developed after literature review. Content validity was established through review by 2 content experts and women with HIV/AIDS. The MOS-HIV, the HIVIS-W and disease status indicators were used in evaluation of construct and criterion-related validity. Findings: Mean score on the HIVSX-FEM was 48.3 (range 4-140). Content validity index was 1.00. Internal consistency reliability was .92. Significant pearson correlations in with the MOS-HIV Overall Health Scale (-0.47, p<.001), and Quality of Life Scale (-0.57, p<.001) provide evidence of criterion-related validity. Evidence of construct validity is shown by correlation with mental health distress (HIVIS-W) (0.58, p<.001), several MOS-HIV Scales (Physical Function -0.48; Role Function -0.48; Social Function -0.45; and Mental Health Distress -0.49; p<.001 for each) and with HIV viral load (0.26, p<.01). Women with AIDS had higher symptom distress than women with HIV (t=2.55, p<0.05). Conclusions: Preliminary testing of the HIVSX-FEM demonstrates reliability, and content, criterion-related and construct validity. Implications: The HIVSX-FEM shows promise for measuring symptom distress in women with HIV/AIDS, in practice and research.
Repository Posting Date:
26-Oct-2011
Date of Publication:
22-Jul-2004
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleDevelopment and Testing of a Scale to Measure Symptom Distress Among Women Living With HIV/AIDSen_GB
dc.identifier.urihttp://hdl.handle.net/10755/151668-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Development and Testing of a Scale to Measure Symptom Distress Among Women Living With HIV/AIDS</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2004</td></tr><tr class="item-conference-date"><td class="label">Conference Date:</td><td class="value">July 22-24, 2004</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Lindberg, Claire E., PhD, RN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">The College of New Jersey</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Associate Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">clindberg6@comcast.net</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">Kathleen Casey, MD; Susan Bataille, RN</td></tr><tr><td colspan="2" class="item-abstract">Objective: Development and testing of an instrument to measure physical symptoms in women with HIV/AIDS. Design: Methodological: Scale development and psychometric testing of the HIV Symptom Scale for Females (HIVSX-FEM). Population, Sample: Population/Dates: Adult women with HIVAIDS. 1999-2003. Two community-residing groups of seropositive women from a state with a high HIV/AIDS rates participated: 8 women in focus groups and 123 women completed questionnaires. The mean age of the participants was 41 (range 24-66). Sixty percent were black, 27% were white and 7% were Latina. Variables: Symptom distress: Measured using the HIVSX-FEM, a 28-item self-report scale. Health-related quality of life: Measured using the Medical Outcomes Scale&ndash;HIV (MOS-HIV). HIV-related mental distress: Measured with the HIV Impact Scale for Women (HIVIS-W). HIV status measured with standard disease indicators. Methods: HIVSX-FEM items were developed after literature review. Content validity was established through review by 2 content experts and women with HIV/AIDS. The MOS-HIV, the HIVIS-W and disease status indicators were used in evaluation of construct and criterion-related validity. Findings: Mean score on the HIVSX-FEM was 48.3 (range 4-140). Content validity index was 1.00. Internal consistency reliability was .92. Significant pearson correlations in with the MOS-HIV Overall Health Scale (-0.47, p&lt;.001), and Quality of Life Scale (-0.57, p&lt;.001) provide evidence of criterion-related validity. Evidence of construct validity is shown by correlation with mental health distress (HIVIS-W) (0.58, p&lt;.001), several MOS-HIV Scales (Physical Function -0.48; Role Function -0.48; Social Function -0.45; and Mental Health Distress -0.49; p&lt;.001 for each) and with HIV viral load (0.26, p&lt;.01). Women with AIDS had higher symptom distress than women with HIV (t=2.55, p&lt;0.05). Conclusions: Preliminary testing of the HIVSX-FEM demonstrates reliability, and content, criterion-related and construct validity. Implications: The HIVSX-FEM shows promise for measuring symptom distress in women with HIV/AIDS, in practice and research.</td></tr></table>en_GB
dc.date.available2011-10-26T11:09:45Z-
dc.date.issued2004-07-22en_GB
dc.date.accessioned2011-10-26T11:09:45Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.